Regeneron Pharmaceuticals
REGN
#371
Rank
โ‚น6.337 T
Marketcap
โ‚น60,449
Share price
-0.67%
Change (1 day)
17.57%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2026 (TTM): โ‚น458.22 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are โ‚น14.91 Billion. In 2025 the company made an earning of โ‚น498.23 Billion, an increase over its 2024 earnings that were of โ‚น455.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น458.22 B-8.03%
2025 โ‚น498.23 B9.43%
2024 โ‚น455.29 B13.83%
2023 โ‚น399.99 B-13.57%
2022 โ‚น462.81 B-47.9%
2021 โ‚น888.30 B144.75%
2020 โ‚น362.95 B56.86%
2019 โ‚น231.37 B-4.87%
2018 โ‚น243.23 B22.86%
2017 โ‚น197.98 B56.3%
2016 โ‚น126.66 B8.55%
2015 โ‚น116.69 B54.53%
2014 โ‚น75.51 B11.14%
2013 โ‚น67.94 B72.13%
2012 โ‚น39.47 B-285.93%
2011 -โ‚น21.24 Billion121.73%
2010 -โ‚น9.58 Billion37.18%
2009 -โ‚น6.99 Billion-14.6%
2008 -โ‚น8.18 Billion-25.02%
2007 -โ‚น10.91 Billion6.32%
2006 -โ‚น10.26 Billion-186.52%
2005 โ‚น11.85 B2103.7%
2004 โ‚น0.53 B-105.66%
2003 -โ‚น9.51 Billion-18.18%
2002 -โ‚น11.62 Billion42.33%
2001 -โ‚น8.17 Billion129.35%
2000 -โ‚น3.56 Billion51.87%
1999 -โ‚น2.35 Billion92.19%
1998 -โ‚น1.22 Billion66.23%
1997 -โ‚น0.74 Billion-55.49%
1996 -โ‚น1.65 Billion103.53%
1995 -โ‚น0.81 Billion-70.89%
1994 -โ‚น2.79 Billion-26.08%
1993 -โ‚น3.77 Billion114.67%
1992 -โ‚น1.76 Billion196.77%
1991 -โ‚น0.6 Billion87.88%
1990 -โ‚น0.32 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.474 T 403.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.503 T 206.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
โ‚น865.56 B 76.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น729.49 B 48.51%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚น154.59 B-68.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น82.83 B-83.14%๐Ÿ‡บ๐Ÿ‡ธ USA